id:"swepub:oai:DiVA.org:liu-204917"
Search: id:"swepub:oai:DiVA.org:liu-204917" > Characterization of...
- 1 of 1
- Previous record
- Next record
- To hitlist
Characterization of reduced astrocyte creatine kinase levels in Alzheimer's disease
-
- Zheng, Tianyu (author)
- Karolinska Inst, Sweden
-
- Kotol, David (author)
- Royal Inst Technol, Sweden
-
- Sjoberg, Rebecca (author)
- Karolinska Inst, Sweden
- show more...
- show less...
- (creator_code:org_t)
- 2024
- 2024
- English.
- In: Glia. - : WILEY. - 0894-1491 .- 1098-1136.
- Journal article (peer-reviewed)
Abstract
Subject headings
Close
- The creatine-phosphocreatine cycle serves as a crucial temporary energy buffering system in the brain, regulated by brain creatine kinase (CKB), in maintaining Adenosine triphosphate (ATP) levels. Alzheimer's disease (AD) has been linked to increased CKB oxidation and loss of its regulatory function, although specific pathological processes and affected cell types remain unclear. In our study, cerebral cortex samples from individuals with AD, dementia with Lewy bodies (DLB), and age-matched controls were analyzed using antibody-based methods to quantify CKB levels and assess alterations associated with disease processes. Two independently validated antibodies exclusively labeled astrocytes in the human cerebral cortex. Combining immunofluorescence (IF) and mass spectrometry (MS), we explored CKB availability in AD and DLB cases. IF and Western blot analysis demonstrated a loss of CKB immunoreactivity correlated with increased plaque load, severity of tau pathology, and Lewy body pathology. However, transcriptomics data and targeted MS demonstrated unaltered total CKB levels, suggesting posttranslational modifications (PTMs) affecting antibody binding. This aligns with altered efficiency at proteolytic cleavage sites indicated in the targeted MS experiment. These findings highlight that the proper function of astrocytes, understudied in the brain compared with neurons, is highly affected by PTMs. Reduction in ATP levels within astrocytes can disrupt ATP-dependent processes, such as the glutamate-glutamine cycle. As CKB and the creatine-phosphocreatine cycle are important in securing constant ATP availability, PTMs in CKB, and astrocyte dysfunction may disturb homeostasis, driving excitotoxicity in the AD brain. CKB and its activity could be promising biomarkers for monitoring early-stage energy deficits in AD. Brain creatine kinase (CKB) mainly expressed in strocytes in the human brain. A loss of CKB immunoreactivity correlated with increased plaque load. CKB antibody binding might be affected by posttranslational modifications. image
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Neurosciences (hsv//eng)
Keyword
- brain creatine kinase; dementia with Lewy bodies; multiplex immunofluorescence; targeted mass spectrometry; temporal cortex
Publication and Content Type
- ref (subject category)
- art (subject category)
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Zheng, Tianyu
- Kotol, David
- Sjoberg, Rebecca
- Mitsios, Nichola ...
- Uhlen, Mathias
- Zhong, Wen
- show more...
- Edfors, Fredrik
- Mulder, Jan
- show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Basic Medicine
- and Neurosciences
- Articles in the publication
- Glia
- By the university
- Linköping University
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
